News

A statistically significant increase in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy compared to placebo was not observed. The safety data were steady

The approval by Therapeutic Goods Administration (TGA) in Australia has triggered a $4m milestone payment to Curis, which is even eligible for sales based royalties of Roche’s Erivedge

The inhaled long-term, once-daily maintenance treatment is also indicated for the reduction of exacerbations in COPD patients with possible future episodes of exacerbations. Breo Ellipta comprises inhaled corticosteroid

This personalized medicine approach may accelerate drug development in ALS and other life-threatening disorders. The partnership will incorporate Denovo’s pharmacogenomic technology into the analysis of biological samples obtained

As per the terms of the agreement, Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline: Relvar Ellipta/Breo

IISIS-SMNRxis designed to alter the splicing of a closely related gene (SMN2) to increase production of fully functional SMN protein. As per the terms of January 2012 agreement,

Hospira had stated that administration of precipitated Piperacillin or Tazobactam in an IV bag or IV line may cause local reactions such as phlebitis, renal impairment, end-organ embolism

The Indian firm recently received a high-level delegation from Kazakhstan that was led by Pharmaceutical Assessment Department chief Ardak U Tulegenova. The delegation inspected the company’s manufacturing unit

Rigosertib inhibits phosphoinositide 3-kinase and polo-like kinase, the two important cellular signaling pathways frequently activated in cancer cells. The patients who failed previous therapy with hypomethylating agents such